Hinge Health, Inc.

# Signal Note: RA Capital Initiates HNGE Position RA Capital's $3.7M entry into Hinge Health signals conviction in the digital musculoskeletal care market, where the company generates recurring SaaS revenue from employers and insurers without traditional drug development risk. The position size (~80K shares, <1% ownership) suggests a portfolio allocation rather than a conviction bet, though RA's focus on healthcare innovation and commercial-stage companies aligns with Hinge's shift toward profitability and enterprise contracting expansion. Key catalysts include 2025 enterprise customer additions and margin progression toward their stated path to operating leverage.